Myeloid lineage switch following CD7-targeted chimeric antigen receptor T-cell therapy in relapsed/refractory T-cell acute lymphoblastic leukemia

Haematologica. 2023 Dec 1;108(12):3511-3516. doi: 10.3324/haematol.2023.283566.
No abstract available

MeSH terms

  • Antigens, CD19
  • Cell Lineage
  • Cell- and Tissue-Based Therapy
  • Humans
  • Immunotherapy, Adoptive
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma* / therapy
  • Receptors, Chimeric Antigen* / genetics
  • T-Lymphocytes

Substances

  • Receptors, Chimeric Antigen
  • Antigens, CD19